Comparison of the 8th edition of TNM staging of oral cancer with the 7th edition and its prognostic significance using clinical depth of invasion and extranodal extension.

AJCC 8th edition C-index Clinical staging DOI Disease-specific survival ENE Head and neck cancer Overall survival TNM staging UICC 8th edition

Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
10 2023
Historique:
received: 11 06 2023
revised: 11 07 2023
accepted: 13 07 2023
medline: 18 8 2023
pubmed: 17 7 2023
entrez: 17 7 2023
Statut: ppublish

Résumé

The 8th edition of the International Union Against Cancer Control/American Joint Committee on Cancer Staging System introduced depth of invasion (DOI) and extranodal extension (ENE) into the staging of oral cavity cancer. We evaluated the prognostic ability of this new staging system compared with the 7th edition using clinical DOI (cDOI) and clinical ENE (cENE). We retrospectively reviewed and restaged 2,118 patients with oral squamous cell carcinoma treated between 2001 and 2018 using cDOI and cENE. Overall and disease-specific survival were used as endpoints to compare the prognostic outcomes of the 7th and 8th editions using Harrell's concordance index (C-index). In total, 305 (14.4 %) cases were upstaged in the T category, 85 (4.0 %) cases were upstaged in the N category, and 280 (13.2 %) cases were upstaged in the overall TNM stage. The introduction of the cDOI increased the C-index and hazard ratio (HR) for each T category. The introduction of cENE increased the N3b category of 85 cases, bringing the total to 94 cases, thereby widening the differences between each N category. In the 8th edition, the C-index and HR for overall TNM stage increased, and the discrimination between stage groups improved. The 8th edition of the TNM clinical staging system using cDOI and cENE predominantly identified patients with a high mortality rate, thus improving the ability to discriminate and prognosticate oral cancer.

Identifiants

pubmed: 37459802
pii: S1368-8375(23)00215-4
doi: 10.1016/j.oraloncology.2023.106519
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106519

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yusuke Yokota (Y)

Department of Oral and Maxillofacial Surgery, Osaka University Graduate School of Dentistry, Osaka, Japan.

Takumi Hasegawa (T)

Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.

Nobuhiro Yamakawa (N)

Department of Oral and Maxillofacial Surgery, Nara Medical University, Nara, Japan.

Shin Rin (S)

Department of Clinical Oral Oncology, Hokkaido Cancer Center, Sapporo, Japan.

Mitsunobu Otsuru (M)

Department of Clinical Oral Oncology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Shin-Ichi Yamada (SI)

Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.

Eiji Hirai (E)

Oral and Maxillofacial Surgery, Oita Red Cross Hospital, Oita, Japan.

Yuichi Ashikaga (Y)

Oral and Maxillofacial Surgery, Graduate School of Dental Medicine, Hokkaido University, Sapporo, Japan.

Kozo Yamamoto (K)

Oral and Maxillofacial Surgery, Oita Red Cross Hospital, Oita, Japan.

Michihiro Ueda (M)

Department of Clinical Oral Oncology, Hokkaido Cancer Center, Sapporo, Japan.

Tadaaki Kirita (T)

Department of Oral and Maxillofacial Surgery, Nara Medical University, Nara, Japan.

Masahiro Umeda (M)

Department of Clinical Oral Oncology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Masaya Akashi (M)

Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.

Hiroshi Kurita (H)

Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.

Yoichi Ohiro (Y)

Oral and Maxillofacial Surgery, Graduate School of Dental Medicine, Hokkaido University, Sapporo, Japan.

Souichi Yanamoto (S)

Department of Oral Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.

Masaya Okura (M)

Department of Oral and Maxillofacial Surgery, Osaka University Graduate School of Dentistry, Osaka, Japan; Oral and Maxillofacial Surgery, Saiseikai Matsusaka General Hospital, Mie, Japan. Electronic address: mokuramokura@yahoo.co.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH